Dr. Luke T. Nordquist, MD
- Medicare services, 2024
- 55,532
- Medicare patients, 2024
- 655
- Part D claims, 2024
- 1,520
- Clinical trials
- 3
- MIPS score, 2024
- 82
- Practice address
- 17607 Gold Plz, Omaha, NE 68130
- Practice phone
- Call (402) 991-8468
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Xcancer
Omaha, Nebraska
Find Dr. Nordquist's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Luke T. Nordquist is a hematologist and oncologist in Omaha, Nebraska
Dr. Nordquist practices at Xcancer in Omaha, Nebraska.
Dr. Nordquist's NPI, 1538149414, was assigned on January 18, 2006. Dr. Nordquist graduated from Creighton University School of Medicine in 1998. Dr. Nordquist holds Nebraska license 22733.
- NPI
- 1538149414NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2961486063
- NPI enumeration date
- January 18, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (402) 991-8468
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 54
- Medical school graduation
- 1998
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Luke T. Nordquist practices at Xcancer in Omaha, Nebraska
Dr. Nordquist's primary practice is Xcancer, at 17607 Gold Plz, Omaha, NE 68130 in Douglas County. The practice phone is (402) 991-8468.
- Xcancer17607 Gold Plz, Omaha, NE 68130 · Douglas CountyPhone(402) 991-8468
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Luke T. Nordquist is affiliated with 7 sites of care and 1 medical group
Dr. Nordquist's primary practice is Xcancer in Omaha, Nebraska. Dr. Nordquist is also affiliated with Methodist Hospital. The medical group on file is XCancer. Dmand AI also links Dr. Nordquist to 4 more hospitals and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Luke T. Nordquist's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nordquist practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Xcancer | Available with a free account |
| +6 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Luke T. Nordquist is one of 80 hematologists and oncologists in Nebraska
Hematology and oncology is Dr. Nordquist's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Nordquist is licensed in Nebraska.
Specialties and state licenses
- Hematology and oncology, NebraskaPrimary
Hematologists and oncologists near Dr. Nordquist
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Luke T. Nordquist billed Medicare for 55,532 services in 2024
CMS data shows 55,532 Medicare services from Dr. Nordquist across 38 procedure codes in 2024, for 655 Medicare patients. Medicare paid $1,735,995 for them. Every service was in an office.
Dr. Nordquist's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Other services
- 2023: 33,1662024: 27,86516%
- Drugs given in the office
- 2023: 27,4682024: 17,77935%
- Lab and pathology
- 2023: 5,3162024: 4,38118%
- Office and hospital visits
- 2023: 2,0602024: 2,0311%
- Surgery
- 2023: 2,2712024: 1,81920%
- Tests and treatments
- 2023: 1,4772024: 99932%
- Imaging
- 2023: 7242024: 6589%
Dr. Nordquist compared with the Nebraska median for hematologists and oncologists, 2024
- Dr. Nordquist
- Nebraska median
- Medicare services
- 55,532vs 1,32242.0 times
- Medicare patients
- 655vs 40861% above
- Part D claims
- 1,481vs 5492.7 times
Medians across 79 hematologists and oncologists in Nebraska with Dmand AI profiles that report each measure.
Dr. Nordquist's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Nordquist?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Nordquist and other hematologists and oncologists in Nebraska.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Luke T. Nordquist treated 655 Medicare patients in 2024, average age 75
CMS counts 655 Medicare patients who saw Dr. Nordquist in 2024. The largest group is 65 to 74, with 347 patients. 75% of them have cancer, and 72% have high cholesterol. Their average risk score is 1.42, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Nordquist's median patient age at 72, with 4% women.
Dr. Nordquist's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Nordquist's Medicare patients by sex, 2024
- Women264%
- Men62996%
Chronic conditions among Dr. Nordquist's Medicare patients, 2024
- Cancer75%
- High cholesterol72%
- High blood pressure69%
- Arthritis43%
- Ischemic heart disease26%
- Chronic kidney disease22%
- Diabetes22%
- Atrial fibrillation18%
Share of Medicare patients with each condition. A patient can have several.
Dr. Nordquist's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women4%
- Men96%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Luke T. Nordquist wrote 1,520 Medicare Part D claims in 2024
In 2024, Dr. Nordquist wrote 1,520 Medicare Part D claims for 194 patients. 42% of them were for generic drugs. CMS names the drug for 1,481 of them, across 11 drugs with 11 or more claims each, at $11,055,230 in total drug cost. In 2023, CMS named 1,555 claims across 12 drugs.
Dr. Nordquist's Part D claims by kind of drug, 2024
- Generic639 claims42%
- Brand-name881 claims58%
Dr. Nordquist's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,5552024: 1,4815%
Drugs named by CMS: 11 in 2024, 12 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Luke T. Nordquist scored 82 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Nordquist for performance year 2024, reported individually. Dr. Nordquist accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nordquist as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Nordquist's MIPS scores, performance year 2024
- 82of 100Final score
- 63.9of 100Quality
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Luke T. Nordquist has worked on 3 clinical trials
Dmand AI links Dr. Nordquist to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Nordquist that name 3 trials.
Conditions in Dr. Nordquist's trials
- Prostatic Neoplasms
- Prostatic Diseases
Investigators on the most trials with Dr. Nordquist
- Christopher M. Pieczonka, MD3 shared trials
- Kevin Dale Courtney, MD2 shared trials
- Gurjyot Kaur Doshi, MD2 shared trials
Recent clinical trials with Dr. Nordquist
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Luke T. Nordquist received $163,378 in industry payments from 2016 to 2025
CMS Open Payments shows 338 general payments to Dr. Nordquist from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 83% of the total. Novartis Pharmaceuticals Corporation paid the most, $135,209. It also lists 21 research payments totaling $19,718 from 2016 to 2025, naming 3 clinical trials.
General payments to Dr. Nordquist by program year, 2016 to 2025
General payments to Dr. Nordquist by kind, 2016 to 2025
- Speaker and faculty fees$135,95383%
- Consulting fees$19,68412%
- Food and beverage$5,2383%
- Travel and lodging$2,2861%
- Education$2180%
Companies that paid Dr. Nordquist the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Luke T. Nordquist graduated from Creighton University School of Medicine
Dr. Nordquist graduated from Creighton University School of Medicine in 1998.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Luke T. Nordquist's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Luke T. Nordquist
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Luke T. Nordquist's NPI number?
Dr. Luke T. Nordquist's NPI number is 1538149414. It was assigned on January 18, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Luke T. Nordquist?
Dr. Luke T. Nordquist is a hematologist and oncologist in Omaha, Nebraska. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Luke T. Nordquist practice?
Dr. Nordquist practices at 17607 Gold Plz, Omaha, NE 68130. Dr. Nordquist's primary practice is Xcancer in Omaha, Nebraska. Dmand AI also links Dr. Nordquist to 4 hospitals and 1 group practice or clinic.
What is Dr. Luke T. Nordquist's office phone number?
The practice phone on file for Dr. Nordquist is (402) 991-8468.
What is Dr. Luke T. Nordquist's medical license number?
Dr. Nordquist holds Nebraska license 22733.
Which hospitals is Dr. Luke T. Nordquist affiliated with?
Dr. Nordquist is affiliated with Methodist Hospital. Dmand AI links Dr. Nordquist to 4 more hospitals.
What medical group is Dr. Luke T. Nordquist part of?
Dr. Nordquist is linked to XCancer.
Does Dr. Luke T. Nordquist accept Medicare?
Yes. CMS data shows Dr. Nordquist billed Medicare for 55,532 services in 2024, and Dr. Nordquist accepts Medicare assignment.
Does Dr. Luke T. Nordquist offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Nordquist as offering telehealth services.
What is Dr. Luke T. Nordquist's MIPS score?
Dr. Nordquist's MIPS final score for performance year 2024 is 82 out of 100, reported individually.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Luke T. Nordquist see?
CMS counts 655 Medicare patients who saw Dr. Nordquist in 2024, with an average age of 75.
What services does Dr. Luke T. Nordquist bill to Medicare?
In 2024, Dr. Nordquist's most billed Medicare services were medicare temporary code (Q9967), injected or infused drug (J0897) and injected or infused drug (J9043).
Where did Dr. Luke T. Nordquist go to medical school?
Dr. Nordquist graduated from Creighton University School of Medicine in 1998.
What drugs does Dr. Luke T. Nordquist prescribe most?
In 2024 Medicare Part D data, Dr. Nordquist's most prescribed drugs by claims were Xtandi, Abiraterone Acetate and Prednisone.
Has Dr. Luke T. Nordquist received payments from drug or device companies?
CMS Open Payments shows $163,378 in general payments to Dr. Nordquist from 24 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Luke T. Nordquist been practicing?
Dr. Nordquist graduated from medical school in 1998, 28 years ago.
Does Dr. Luke T. Nordquist do research?
Dr. Nordquist has worked on 3 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Nebraska by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card